Complications of haemophilia in babies (first two years of life): a report from the Centers for Disease Control and Prevention Universal Data Collection System
- PMID: 27813214
- PMCID: PMC5354941
- DOI: 10.1111/hae.13081
Complications of haemophilia in babies (first two years of life): a report from the Centers for Disease Control and Prevention Universal Data Collection System
Abstract
Aim: To describe the prevalence and complications in babies ≤2 years with haemophilia.
Methods: We used a standardized collection tool to obtain consented data on eligible babies aged ≤2 years with haemophilia enrolled in the Centers for Disease Control and Prevention Universal Data Collection System surveillance project at US Hemophilia Treatment Centers (HTCs).
Results: Of 547 babies, 82% had haemophilia A, and 70% were diagnosed within one month of birth. Diagnosis was prompted by known maternal carrier status (40%), positive family history (23%), bleeding (35%) and unknown 2%; 81% bled during the first two years. The most common events were bleeding (circumcision, soft tissue, oral bleeding) and head injury. There were 46 episodes of intracranial haemorrhage (ICH) in 37 babies (7%): 18 spontaneous, 14 delivery related, 11 traumatic, 2 procedure related and 1 unknown cause. Of the 176 central venous access devices (CVADs) in 148 (27%) babies, there were 137 ports, 22 surgically inserted central catheters and 20 peripherally inserted central catheters. Ports had the lowest complication rates. Inhibitors occurred in 109 (20%) babies who experienced higher rates of ICH (14% vs. 5%; P = 0.002), CVAD placement (61% vs. 19%; P < 0.001) and CVAD complications (44% vs. 26%; P < 0.001). The most common replacement therapy was recombinant clotting factor concentrates.
Conclusion: Bleeding events in haemophilic babies ≤2 years were common; no detectable difference in the rates of ICH by the mode of delivery was noted. Neonatal factor exposure did not affect the inhibitor rates. Minor head trauma, soft tissue and oropharyngeal bleeding were the leading indications for treatment.
Keywords: babies; central venous access device; haemophilia; head trauma; inhibitors; intracranial hemorrhage.
© 2016 John Wiley & Sons Ltd.
Figures
Similar articles
-
Sites of initial bleeding episodes, mode of delivery and age of diagnosis in babies with haemophilia diagnosed before the age of 2 years: a report from The Centers for Disease Control and Prevention's (CDC) Universal Data Collection (UDC) project.Haemophilia. 2009 Nov;15(6):1281-90. doi: 10.1111/j.1365-2516.2009.02074.x. Epub 2009 Jul 22. Haemophilia. 2009. PMID: 19637999
-
Central venous access device-related infections in patients with haemophilia.J Paediatr Child Health. 2013 Mar;49(3):242-5. doi: 10.1111/jpc.12112. Epub 2013 Feb 26. J Paediatr Child Health. 2013. PMID: 23438133
-
Burden of illness and costs among paediatric haemophilia patients with and without central venous access devices treated in US hospitals.Haemophilia. 2018 May;24(3):e93-e102. doi: 10.1111/hae.13404. Epub 2018 Mar 25. Haemophilia. 2018. PMID: 29577531
-
Overview of the use of implantable venous access devices in the management of children with inherited bleeding disorders.Haemophilia. 2006 Dec;12 Suppl 6:87-93. doi: 10.1111/j.1365-2516.2006.01371.x. Haemophilia. 2006. PMID: 17123400 Review.
-
Consensus recommendations for use of central venous access devices in haemophilia.Haemophilia. 2004 Sep;10(5):629-48. doi: 10.1111/j.1365-2516.2004.00943.x. Haemophilia. 2004. PMID: 15357790 Review.
Cited by
-
Evaluating the Effectiveness of Prophylactic Strategies for Hemophilia A Management: A Real-World, Longitudinal Observational Study.Drugs Real World Outcomes. 2024 Dec;11(4):711-723. doi: 10.1007/s40801-024-00452-z. Epub 2024 Nov 20. Drugs Real World Outcomes. 2024. PMID: 39565566 Free PMC article.
-
Simoctocog alfa (Nuwiq®) in children: early steps in life's journey for people with severe hemophilia A.Ther Adv Hematol. 2024 May 9;15:20406207241245511. doi: 10.1177/20406207241245511. eCollection 2024. Ther Adv Hematol. 2024. PMID: 38737006 Free PMC article. Review.
-
Gender equity in hemophilia: need for healthcare, familial, and societal advocacy.Front Med (Lausanne). 2024 Apr 5;11:1345496. doi: 10.3389/fmed.2024.1345496. eCollection 2024. Front Med (Lausanne). 2024. PMID: 38646558 Free PMC article. Review.
-
Clinical and treatment characteristics of infants and toddlers less than 2 years of age with hemophilia.Blood Adv. 2024 Jun 11;8(11):2707-2717. doi: 10.1182/bloodadvances.2023012486. Blood Adv. 2024. PMID: 38547443 Free PMC article.
-
A post hoc analysis of previously untreated patients with severe hemophilia A who developed inhibitors in the PUPs A-LONG trial.Blood Adv. 2024 Mar 26;8(6):1494-1503. doi: 10.1182/bloodadvances.2023011475. Blood Adv. 2024. PMID: 38266154 Free PMC article. Clinical Trial.
References
-
- Kulkarni R, Soucie JM, Lusher J, et al. Sites of initial bleeding episodes, mode of delivery and age of diagnosis in babies with haemophilia diagnosed before the age of 2 years: a report from The Centers for Disease Control and Prevention’s (CDC) Universal Data Collection (UDC) project. Haemophilia. 2009;15:1281–90. - PubMed
-
- Kulkarni R, Soucie JM. Pediatric hemophilia: a review. Semin Thromb Hemost. 2011;37:737–44. - PubMed
-
- Kenet G, Chan AK, Soucie JM, Kulkarni R. Bleeding disorders in neonates. Haemophilia. 2010;5:168–75. - PubMed
-
- Ljung RC. Intracranial haemorrhage in haemophilia A and B. Br J Haematol. 2008;140:378–84. - PubMed
-
- Valentino LA, Ewenstein B, Navickis RJ, Wilkes MM. Central venous access devices in haemophilia. Haemophilia. 2004;10:134–46. - PubMed
MeSH terms
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical

